TABLE 6.
Multidrug resistance profile of the Salmonella isolatesa
| MDR phenotypes | No. of antibiotics group | Name of the groups | No. of isolates (%) | Serotypes | MDR prevalence |
|---|---|---|---|---|---|
| AK, AMP, CAZ, XNL, CL, GEN, COT | 5 | Aminoglycosides, penicillins, cephalosporins, phenicol, sulfonamides | 2 (7.69) | S. Mbandaka | 11.53% |
| AK, AMP, CAZ, XNL, CL, GEN, TE, COT | 6 | Aminoglycosides, penicillins, cephalosporins, phenicol, tetracyclines, sulfonamides | 1 (3.85) | S. Typhimurium |
AK, amikacin; AMP, ampicillin; CAZ, ceftazidime; XNL, ceftiofur; CL, chloramphenicol; DOX, doxycycline; GEN, gentamicin; IMP, imipenem; TE, tetracycline; COT, trimethoprim/sulfamethoxazole.